HIV genotypic resistance among pregnant women initiating ART in Uganda: a baseline evaluation of participants in the Option B+ clinical trial

BACKGROUND: Pre-treatment HIV drug resistance is a threat to elimination of mother to child HIV transmission and could lead to virological failure among HIV-positive pregnant women. We analysed genotypic HIV drug resistance (HIVDR) of baseline samples of participants enrolled in the Option B+ clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Amone, Alexander, Wavamunno, Priscilla, Gabagaya, Grace, Rukundo, Gordon, Namale-Matovu, Joyce, Malamba, Samuel S, Lubega, Irene, Homsy, Jaco, King, Rachel, Nakabiito, Clemensia, Nolan, Monica, Fowler, Mary Glenn, Musoke, Philippa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Makerere Medical School 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117495/
https://www.ncbi.nlm.nih.gov/pubmed/37092059
http://dx.doi.org/10.4314/ahs.v22i4.48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117495/
https://www.ncbi.nlm.nih.gov/pubmed/37092059
http://dx.doi.org/10.4314/ahs.v22i4.48

Ejemplares similares